
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
“MODERN APPROACHES TO RHEUMATOID ARTHRITIS: CLINICAL MANIFESTATIONS, TREATMENT ADVANCES, AND FUTURE PROSPECTSâ€
Ms. Sakshi V. Mane*, Ms. Anuja C. Mohite, Mrs. Nita V. Khade
. Abstract Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disorder, characterized by gradual joint damage, associated systemic conditions, and a complex immune-driven mechanism. Although it has been studied extensively, the precise cause of RA is still not understood. Research from genetic investigations, tissue evaluations, animal studies, and clinical findings underscores immune dysfunction involving stromal tissues, cytokine interactions, and the production of autoantibodies. Often, a pre-clinical phase occurs before the appearance of clinical symptoms, which is identified by the presence of circulating autoantibodies, changes in metabolism, and in flammatory substances. The clinical presentation is characterized by synovitis and systemic complications affecting the cardiovascular, metabolic, and skeletal systems. Recent developments in diagnostic markers, biologic treatments, and integrated care approaches have enhanced patient outcomes, decreasing disease activity and averting systemic complications. This review highlights the current insights into the pathophysiology, clinical characteristics, and treatment strategies of RA, stressing the significance of prompt diagnosis and thorough management. Keywords: Rheumatoid arthritis, Autoimmune disorder, Synovitis, Cytokines, Biologics, Systemic complications etc. [Full Text Article] [Download Certificate] |
